Literature DB >> 21611746

The application of gene co-expression network reconstruction based on CNVs and gene expression microarray data in breast cancer.

Yan Xu1, Huizi Duanmu, Zhiqiang Chang, Shanzhen Zhang, Zhenqi Li, Zihui Li, Yufeng Liu, Kening Li, Fujun Qiu, Xia Li.   

Abstract

Copy number variations (CNVs) are one type of the human genetic variations and are pervasive in the human genome. It has been confirmed that they can play a causal role in complex diseases. Previous studies of CNVs focused more on identifying the disease-specific CNV regions or candidate genes on these CNV regions, but less on the synergistic actions between genes on CNV regions and other genes. Our research combined the CNVs with related gene co-expression to reconstruct gene co-expression network by using single nucleotide polymorphism microarray datasets and gene microarray datasets of breast cancer, and then extracted the modules which connected densely inside and analyzed the functions of modules. Interestingly, all of these modules' functions were related to breast cancer according to our enrichment analysis, and most of the genes in these modules have been reported to be involved in breast cancer. Our findings suggested that integrating CNVs and gene co-expressed relations was an available way to analyze the roles of CNV genes and their synergistic genes in breast cancer, and provided a novel insight into the pathological mechanism of breast cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21611746     DOI: 10.1007/s11033-011-0902-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  74 in total

1.  Overexpression of MTERFD1 or MTERFD3 impairs the completion of mitochondrial DNA replication.

Authors:  Anne K Hyvärinen; Jaakko L O Pohjoismäki; Ian J Holt; Howard T Jacobs
Journal:  Mol Biol Rep       Date:  2010-06-25       Impact factor: 2.316

2.  Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.

Authors:  Dipak Datta; Jesse A Flaxenburg; Sreenivas Laxmanan; Christopher Geehan; Martin Grimm; Ana Maria Waaga-Gasser; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

3.  Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer.

Authors:  Edgar Dahl; Ariane Sadr-Nabavi; Eva Klopocki; Beate Betz; Susanne Grube; Rene Kreutzfeld; Marina Himmelfarb; Han-Xiang An; Stephen Gelling; Irina Klaman; Bernd Hinzmann; Glen Kristiansen; Robert Grützmann; Ruprecht Kuner; Beate Petschke; Kerstin Rhiem; Kai Wiechen; Christine Sers; Otmar Wiestler; Achim Schneider; Heinz Höfler; Jörg Nährig; Manfred Dietel; Reinhold Schäfer; André Rosenthal; Rita Schmutzler; Matthias Dürst; Alfons Meindl; Dieter Niederacher
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

4.  Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.

Authors:  Jan Budczies; Wilko Weichert; Aurelia Noske; Berit Maria Müller; Claudia Weller; Timo Wittenberger; Hans-Peter Hofmann; Manfred Dietel; Carsten Denkert; Volker Gekeler
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

5.  The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.

Authors:  Christine A Iacobuzio-Donahue; Pedram Argani; Paula M Hempen; Jessa Jones; Scott E Kern
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

Review 6.  Aberrant function of the Ras signal transduction pathway in human breast cancer.

Authors:  G J Clark; C J Der
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

7.  The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; Badreddin Edris; Rui Li; Kelli Montgomery; Shirley Zhu; Sushama Varma; Robert J Marinelli; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

8.  Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.

Authors:  Tomomi Ueki; Jae-Hyun Park; Toshihiko Nishidate; Kyoko Kijima; Koichi Hirata; Yusuke Nakamura; Toyomasa Katagiri
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

9.  Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

Authors:  A Bergamaschi; E Tagliabue; T Sørlie; B Naume; T Triulzi; R Orlandi; H G Russnes; J M Nesland; R Tammi; P Auvinen; V-M Kosma; S Ménard; A-L Børresen-Dale
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

10.  Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.

Authors:  Emma Jaeger; Emily Webb; Kimberley Howarth; Luis Carvajal-Carmona; Andrew Rowan; Peter Broderick; Axel Walther; Sarah Spain; Alan Pittman; Zoe Kemp; Kate Sullivan; Karl Heinimann; Steven Lubbe; Enric Domingo; Ella Barclay; Lynn Martin; Maggie Gorman; Ian Chandler; Jayaram Vijayakrishnan; Wendy Wood; Elli Papaemmanuil; Steven Penegar; Mobshra Qureshi; Susan Farrington; Albert Tenesa; Jean-Baptiste Cazier; David Kerr; Richard Gray; Julian Peto; Malcolm Dunlop; Harry Campbell; Huw Thomas; Richard Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

View more
  11 in total

1.  Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.

Authors:  Yue Zhao; Yimin Wang; Fudi Zhu; Jiayu Zhang; Xiao Ma; Dongwei Zhang
Journal:  Clin Exp Med       Date:  2020-01-24       Impact factor: 3.984

2.  A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkers.

Authors:  Ahmed Essaghir; Jean-Baptiste Demoulin
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

Review 3.  Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research.

Authors:  Natini Jinawath; Sacarin Bunbanjerdsuk; Maneerat Chayanupatkul; Nuttapong Ngamphaiboon; Nithi Asavapanumas; Jisnuson Svasti; Varodom Charoensawan
Journal:  J Transl Med       Date:  2016-11-22       Impact factor: 5.531

4.  A matrix rank based concordance index for evaluating and detecting conditional specific co-expressed gene modules.

Authors:  Zhi Han; Jie Zhang; Guoyuan Sun; Gang Liu; Kun Huang
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

5.  In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.

Authors:  Claudia Cava; Gloria Bertoli; Antonio Colaprico; Gianluca Bontempi; Giancarlo Mauri; Isabella Castiglioni
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

6.  Generalized gene co-expression analysis via subspace clustering using low-rank representation.

Authors:  Tongxin Wang; Jie Zhang; Kun Huang
Journal:  BMC Bioinformatics       Date:  2019-05-01       Impact factor: 3.169

7.  Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.

Authors:  Denise M Wolf; Marc E Lenburg; Christina Yau; Aaron Boudreau; Laura J van 't Veer
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

8.  Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma.

Authors:  Ling Li; Baofeng Lian; Chao Li; Wei Li; Jing Li; Yuannv Zhang; Xianghuo He; Yixue Li; Lu Xie
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

9.  Alpha-tryptase gene variation is associated with levels of circulating IgE and lung function in asthma.

Authors:  A M Abdelmotelb; M J Rose-Zerilli; S J Barton; S T Holgate; A F Walls; J W Holloway
Journal:  Clin Exp Allergy       Date:  2014-06       Impact factor: 5.018

10.  Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.

Authors:  Nikolai V Litviakov; Nadezhda V Cherdyntseva; Matvey M Tsyganov; Elena M Slonimskaya; Marina K Ibragimova; Polina V Kazantseva; Julia Kzhyshkowska; Eugeniy L Choinzonov
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.